AMH and polycystic ovary syndrome: Our health economics model highlights the potential economic impact of implementing the Elecsys AMH Plus immunoassay in the UK NHS, based on recently published guidelines that allow the replacement of AFC determination by TVUS with AMH measurement for the assessment of PCOM in PCOS [23].